[1] |
Chen W, Zheng R, Baade PD, et a1. Cancer statistics in China, 2015 [J]. CA Cancer J Clin, 2016, 66(2):115-132.
|
[2] |
Ye Lc, Liu TS, Ren L, et a1. Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-1imited metastases [J]. J Clin Oncol, 2013, 31(16):1931-1938.
|
[3] |
顾晋. 结直肠癌规范化外科治疗的问题与对策[J]. 中华消化外科杂志, 2015, 14(6):441-444.
|
[4] |
Adam R, de Gramont A, Figueras J, et al. Managing synchronous liver metastases from colorectal cancer: a multidiciplinary international consensus [J]. Cancer Treat Rev, 2015, 41(9):729-741.
|
[5] |
中华医学会外科学分会胃肠外科学组,中华医学会外科学分会结直肠肛门外科学组,中国抗癌协会大肠癌专业委员会,等.结直肠癌肝转移诊断和综合治疗指南(2016版) [J].中华消化外科杂志, 2016, 15(8):755-767.
|
[6] |
王盛,喻春钊. 结直肠癌肝转移的治疗现状[J/CD].中华普通外科学文献(电子版), 2017, 11(1):51-55.
|
[7] |
忠诚,苏冀. 结直肠癌肝转移的转化治疗策略[J/CD]. 中华结直肠疾病电子杂志, 2013, 2(5):217-220.
|
[8] |
Haraldsdottir S, Wu C, Bloomston M, et al.What is the optimal neo-adjuvant treatment for liver metastasis? [J]. Ther Adv Med Oncol, 2013, 5(4):221-234.
|
[9] |
Yin Z, Liu C, Chen Y, et al. Timing of hepatectomy in resectable synchronous colorectal liver metastases (SCRLM): Simultaneous or delayed? [J]. Hepatology, 2013, 57(6):2346-2357.
|
[10] |
杨亮亮,任黎. 同时性结肠癌肝转移转化治疗后一期切除原发灶及肝转移灶[J]. 中华消化外科杂志, 2016, 15(2):185-190.
|
[11] |
Waisberg J, Lvankovics IG. Liver-first approach of colorectal cancer with synchronous hepatic metastases: A reverse strategy [J]. World J Hepatol, 2015, 7(11):1444-1449.
|
[12] |
Rahbari NN, Bork U, Schölch S, et al. Metastatic Spread Emerging From Liver Metastases of Colorectal Cancer: Does the Seed Leave the Soil Again? [J]. Ann Surg, 2016, 263(2):345-352.
|
[13] |
Wei M, He Y, Wang J, et al. Laparoscopic versus open hepatectomy with or without synchronous colectomy for colorectal liver metastasis: a meta-analysis [J]. PLoS One, 2014, 9(1):e87461.
|
[14] |
戴朝六,徐锋. 个体化治疗直肠癌同时性肝转移[J].中华消化外科杂志, 2014, 13(3):175-179.
|